Global Bevacizumab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bevacizumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bevacizumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bevacizumab by Country/Region, 2017, 2022 & 2028

2.2 Bevacizumab Segment by Type

2.2.1 Avastin (bevacizumab)

2.2.2 Mvasi (bevacizumab-awwb)

2.3 Bevacizumab Sales by Type

2.3.1 Global Bevacizumab Sales Market Share by Type (2017-2022)

2.3.2 Global Bevacizumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bevacizumab Sale Price by Type (2017-2022)

2.4 Bevacizumab Segment by Application

2.4.1 Cancer

2.4.2 Eye Diease

2.5 Bevacizumab Sales by Application

2.5.1 Global Bevacizumab Sale Market Share by Application (2017-2022)

2.5.2 Global Bevacizumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bevacizumab Sale Price by Application (2017-2022)

3 Global Bevacizumab by Company

3.1 Global Bevacizumab Breakdown Data by Company

3.1.1 Global Bevacizumab Annual Sales by Company (2020-2022)

3.1.2 Global Bevacizumab Sales Market Share by Company (2020-2022)

3.2 Global Bevacizumab Annual Revenue by Company (2020-2022)

3.2.1 Global Bevacizumab Revenue by Company (2020-2022)

3.2.2 Global Bevacizumab Revenue Market Share by Company (2020-2022)

3.3 Global Bevacizumab Sale Price by Company

3.4 Key Manufacturers Bevacizumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bevacizumab Product Location Distribution

3.4.2 Players Bevacizumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bevacizumab by Geographic Region

4.1 World Historic Bevacizumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Bevacizumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bevacizumab Annual Revenue by Geographic Region

4.2 World Historic Bevacizumab Market Size by Country/Region (2017-2022)

4.2.1 Global Bevacizumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bevacizumab Annual Revenue by Country/Region

4.3 Americas Bevacizumab Sales Growth

4.4 APAC Bevacizumab Sales Growth

4.5 Europe Bevacizumab Sales Growth

4.6 Middle East & Africa Bevacizumab Sales Growth

5 Americas

5.1 Americas Bevacizumab Sales by Country

5.1.1 Americas Bevacizumab Sales by Country (2017-2022)

5.1.2 Americas Bevacizumab Revenue by Country (2017-2022)

5.2 Americas Bevacizumab Sales by Type

5.3 Americas Bevacizumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bevacizumab Sales by Region

6.1.1 APAC Bevacizumab Sales by Region (2017-2022)

6.1.2 APAC Bevacizumab Revenue by Region (2017-2022)

6.2 APAC Bevacizumab Sales by Type

6.3 APAC Bevacizumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bevacizumab by Country

7.1.1 Europe Bevacizumab Sales by Country (2017-2022)

7.1.2 Europe Bevacizumab Revenue by Country (2017-2022)

7.2 Europe Bevacizumab Sales by Type

7.3 Europe Bevacizumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bevacizumab by Country

8.1.1 Middle East & Africa Bevacizumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bevacizumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Bevacizumab Sales by Type

8.3 Middle East & Africa Bevacizumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bevacizumab

10.3 Manufacturing Process Analysis of Bevacizumab

10.4 Industry Chain Structure of Bevacizumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bevacizumab Distributors

11.3 Bevacizumab Customer

12 World Forecast Review for Bevacizumab by Geographic Region

12.1 Global Bevacizumab Market Size Forecast by Region

12.1.1 Global Bevacizumab Forecast by Region (2023-2028)

12.1.2 Global Bevacizumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bevacizumab Forecast by Type

12.7 Global Bevacizumab Forecast by Application

13 Key Players Analysis

13.1 Genentech

13.1.1 Genentech Company Information

13.1.2 Genentech Bevacizumab Product Offered

13.1.3 Genentech Bevacizumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Genentech Main Business Overview

13.1.5 Genentech Latest Developments

14 Research Findings and Conclusion

Table 1. Bevacizumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bevacizumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Avastin (bevacizumab)

Table 4. Major Players of Mvasi (bevacizumab-awwb)

Table 5. Global Bevacizumab Sales by Type (2017-2022) & (K Units)

Table 6. Global Bevacizumab Sales Market Share by Type (2017-2022)

Table 7. Global Bevacizumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Bevacizumab Revenue Market Share by Type (2017-2022)

Table 9. Global Bevacizumab Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Bevacizumab Sales by Application (2017-2022) & (K Units)

Table 11. Global Bevacizumab Sales Market Share by Application (2017-2022)

Table 12. Global Bevacizumab Revenue by Application (2017-2022)

Table 13. Global Bevacizumab Revenue Market Share by Application (2017-2022)

Table 14. Global Bevacizumab Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Bevacizumab Sales by Company (2020-2022) & (K Units)

Table 16. Global Bevacizumab Sales Market Share by Company (2020-2022)

Table 17. Global Bevacizumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Bevacizumab Revenue Market Share by Company (2020-2022)

Table 19. Global Bevacizumab Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Bevacizumab Producing Area Distribution and Sales Area

Table 21. Players Bevacizumab Products Offered

Table 22. Bevacizumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Bevacizumab Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Bevacizumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Bevacizumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Bevacizumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Bevacizumab Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Bevacizumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Bevacizumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Bevacizumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Bevacizumab Sales by Country (2017-2022) & (K Units)

Table 34. Americas Bevacizumab Sales Market Share by Country (2017-2022)

Table 35. Americas Bevacizumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Bevacizumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Bevacizumab Sales by Type (2017-2022) & (K Units)

Table 38. Americas Bevacizumab Sales Market Share by Type (2017-2022)

Table 39. Americas Bevacizumab Sales by Application (2017-2022) & (K Units)

Table 40. Americas Bevacizumab Sales Market Share by Application (2017-2022)

Table 41. APAC Bevacizumab Sales by Region (2017-2022) & (K Units)

Table 42. APAC Bevacizumab Sales Market Share by Region (2017-2022)

Table 43. APAC Bevacizumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Bevacizumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Bevacizumab Sales by Type (2017-2022) & (K Units)

Table 46. APAC Bevacizumab Sales Market Share by Type (2017-2022)

Table 47. APAC Bevacizumab Sales by Application (2017-2022) & (K Units)

Table 48. APAC Bevacizumab Sales Market Share by Application (2017-2022)

Table 49. Europe Bevacizumab Sales by Country (2017-2022) & (K Units)

Table 50. Europe Bevacizumab Sales Market Share by Country (2017-2022)

Table 51. Europe Bevacizumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Bevacizumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Bevacizumab Sales by Type (2017-2022) & (K Units)

Table 54. Europe Bevacizumab Sales Market Share by Type (2017-2022)

Table 55. Europe Bevacizumab Sales by Application (2017-2022) & (K Units)

Table 56. Europe Bevacizumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Bevacizumab Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Bevacizumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Bevacizumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Bevacizumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Bevacizumab Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Bevacizumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Bevacizumab Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Bevacizumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Bevacizumab

Table 66. Key Market Challenges & Risks of Bevacizumab

Table 67. Key Industry Trends of Bevacizumab

Table 68. Bevacizumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Bevacizumab Distributors List

Table 71. Bevacizumab Customer List

Table 72. Global Bevacizumab Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Bevacizumab Sales Market Forecast by Region

Table 74. Global Bevacizumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Bevacizumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Bevacizumab Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Bevacizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Bevacizumab Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Bevacizumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Bevacizumab Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Bevacizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Bevacizumab Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Bevacizumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Bevacizumab Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Bevacizumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Bevacizumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Bevacizumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Bevacizumab Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Bevacizumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Bevacizumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Bevacizumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. Genentech Basic Information, Bevacizumab Manufacturing Base, Sales Area and Its Competitors

Table 93. Genentech Bevacizumab Product Offered

Table 94. Genentech Bevacizumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Genentech Main Business

Table 96. Genentech Latest Developments

Table 97. Amgen Basic Information, Bevacizumab Manufacturing Base, Sales Area and Its Competitors

Table 98. Amgen Bevacizumab Product Offered

Table 99. Amgen Bevacizumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Amgen Main Business

Table 101. Amgen Latest Developments

List of Figures

Figure 1. Picture of Bevacizumab

Figure 2. Bevacizumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bevacizumab Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Bevacizumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bevacizumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Avastin (bevacizumab)

Figure 10. Product Picture of Mvasi (bevacizumab-awwb)

Figure 11. Global Bevacizumab Sales Market Share by Type in 2021

Figure 12. Global Bevacizumab Revenue Market Share by Type (2017-2022)

Figure 13. Bevacizumab Consumed in Cancer

Figure 14. Global Bevacizumab Market: Cancer (2017-2022) & (K Units)

Figure 15. Bevacizumab Consumed in Eye Diease

Figure 16. Global Bevacizumab Market: Eye Diease (2017-2022) & (K Units)

Figure 17. Global Bevacizumab Sales Market Share by Application (2017-2022)

Figure 18. Global Bevacizumab Revenue Market Share by Application in 2021

Figure 19. Bevacizumab Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Bevacizumab Revenue Market Share by Company in 2021

Figure 21. Global Bevacizumab Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Bevacizumab Revenue Market Share by Geographic Region in 2021

Figure 23. Global Bevacizumab Sales Market Share by Region (2017-2022)

Figure 24. Global Bevacizumab Revenue Market Share by Country/Region in 2021

Figure 25. Americas Bevacizumab Sales 2017-2022 (K Units)

Figure 26. Americas Bevacizumab Revenue 2017-2022 ($ Millions)

Figure 27. APAC Bevacizumab Sales 2017-2022 (K Units)

Figure 28. APAC Bevacizumab Revenue 2017-2022 ($ Millions)

Figure 29. Europe Bevacizumab Sales 2017-2022 (K Units)

Figure 30. Europe Bevacizumab Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Bevacizumab Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Bevacizumab Revenue 2017-2022 ($ Millions)

Figure 33. Americas Bevacizumab Sales Market Share by Country in 2021

Figure 34. Americas Bevacizumab Revenue Market Share by Country in 2021

Figure 35. United States Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Bevacizumab Sales Market Share by Region in 2021

Figure 40. APAC Bevacizumab Revenue Market Share by Regions in 2021

Figure 41. China Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Bevacizumab Sales Market Share by Country in 2021

Figure 48. Europe Bevacizumab Revenue Market Share by Country in 2021

Figure 49. Germany Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Bevacizumab Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Bevacizumab Revenue Market Share by Country in 2021

Figure 56. Egypt Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Bevacizumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Bevacizumab in 2021

Figure 62. Manufacturing Process Analysis of Bevacizumab

Figure 63. Industry Chain Structure of Bevacizumab

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles